Streptococcal diseases worldwide: present status and prospects

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Streptococcal infections are prevalent worldwide, particularly in tropical regions.
• Group A streptococci cause rheumatic fever and glomerulonephritis, with higher incidence in tropical countries.
• Group B streptococci pose risks to neonates, and other streptococci cause pneumonia, endocarditis, and dental caries.

Purpose of the Study:

• To review recent advancements in understanding and controlling streptococcal infections.
• To explore the potential for developing vaccines against Group A and Group B streptococci.
• To highlight progress in managing other streptococcal diseases like pneumonia and endocarditis.

Main Methods:

• Analysis of M-protein structure and epitopes in Group A streptococcus.
• Synthesis of immunodominant polypeptides for potential vaccine development.
• Identification of chemical structures for Group B streptococcal types.

Main Results:

• Encouraging results from M-protein analysis and synthetic analogue preparation.
• Increased realism in developing a streptococcal vaccine for Group A infections.
• Progress in identifying Group B streptococcal types for vaccine or immunoglobulin development.

Conclusions:

• A streptococcal vaccine for Group A infections is becoming more feasible.
• Vaccine development for Group B streptococcal infections is a future possibility.
• Advances in research promise better control strategies for various streptococcal pathogens.